Richard Hopkins video, page-26

Fair enough. I guess as I read through all the announcements it is kind of there and what's missing is the investors reading it and responding! I can't work out if it is PYCs past or dampeners over time like Dr Chris and BE that have kept a surpression factor on the SP responding. Either way it's up to management or the IR team to get an audience because at the moment they only seem to have us. When I attended the Investor presentations last year I came away from the lunch feeling like the message was good but there was no audience - maybe it is time for a Nick Woolfe type character to return or a US based IR team? Hopefully RH has a meaningful strategy around this cause there is NO better time to be meeting with investors and be presenting results like they have been getting (and might be about to get) then now when you are not asking for any cash.

I know I have been positive that they are heads down working the science but a few of the people here have got me thinking and if the strategy piece that has been worked on is not made publically clearer in particular with timelines and milestones then RH is not acting like a CEO but more like a CSO2. If they need to return to the market for captital in a few years time then $10m for 5 or 10% dilution is what they whould be going for and the way to do that is get the MCAP over the next 2 years up to $100-200m. To do this RH needs to be on the road in the investor community not the science community and not the same old investor community - other brokers, Melbourne/Sydney investment families & UHNW, pharma VC funds, a full international roadshow is what is need I suspect - this will need a northern hemisphere IR team.

The person I spoke to about this seemed to think that if there was tumor cell death as is implied then it is pretty massive (as a layman I think I am more frustrated that this significance is not clear in the announcements) and all that is needed to smash it out of the park is demonstrate the same without direct injection. Hence if that is now the animal models being undertaken I would have appreciated being informed via ASX announcement that it had started so I think I am starting to come around to the thinking of some here - I agree with Dr Chris that we don't need a mouse by mouse assessment of progress but a start of program and an expected endpoint would be welcome. If these models have started and there is a reasonable expectation of some news inside a few months then if I sold stock at 1-1.2c recently I'd be annoyed if I wasn't aware it could be that close. I guess I am only just starting to realise how big this could really be if it makes the next step from direct injection into the tumor and the only think I can liken it to is that we seem to have a drill rig active over a HIGHLY prospective area (test drill holes came back with visible seams of gold according to my scientific friend) and I'm not sure all investors are informed that they now drilling - maybe they are even at total depth and waiting for the assay results. I suppose the alternative is that I am not paying enough attention and the news is out there but if we have to ferret it out by finding video presentations online then I think the company is underselling its success - or keeping its shareholders uninformed. The former is humility and welcome but the latter has bigger consequences.